Profile
Michael M.
Derkacz currently works at Braeburn, Inc., as President, Chief Executive Officer & Director from 2017.
Mr. Derkacz also formerly worked at Cephalon, Inc., as Vice President, Teva Pharmaceutical Industries Ltd., as Vice President & General Manager-CNS from 2011 to 2015, and Auspex Pharmaceuticals, Inc., as Senior Vice President.
Mr. Derkacz received his undergraduate degree in 1991 from The University of Texas at Austin.
Michael M. Derkacz active positions
| Companies | Position | Start |
|---|---|---|
| BRAEBURN INC. | Chief Executive Officer | 2017-06-04 |
Former positions of Michael M. Derkacz
| Companies | Position | End |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Training of Michael M. Derkacz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Braeburn, Inc.
Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products for opioid use disorder | Commercial Services |
- Stock Market
- Insiders
- Michael M. Derkacz
















